Literature DB >> 7869033

Antibody-mediated autoimmune myocarditis depends on genetically determined target organ sensitivity.

L Liao1, R Sindhwani, M Rojkind, S Factor, L Leinwand, B Diamond.   

Abstract

Injury to cardiac myocytes often leads to the production of anti-myosin antibodies. While these antibodies are a marker of myocardial injury, their contribution to pathogenesis in diseases such as autoimmune myocarditis or rheumatic fever is much less clear. We demonstrate in this report that monoclonal anti-myosin antibodies can mediate myocarditis in a susceptible mouse strain. Additionally, we show disease susceptibility depends on the presence of myosin or a myosin-like molecule in cardiac extracellular matrix. This study demonstrates that susceptibility to autoimmune heart disease depends not only on the activation of self-reactive lymphocytes but also on genetically determined target organ sensitivity to autoantibodies.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7869033      PMCID: PMC2191921          DOI: 10.1084/jem.181.3.1123

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  28 in total

1.  Myocarditis in experimental Coxsackie B-3 infection.

Authors:  E I GRODUMS; G DEMPSTER
Journal:  Can J Microbiol       Date:  1959-12       Impact factor: 2.419

2.  Heart-specific autoantibodies induced by Coxsackievirus B3: identification of heart autoantigens.

Authors:  F L Alvarez; N Neu; N R Rose; S W Craig; K W Beisel
Journal:  Clin Immunol Immunopathol       Date:  1987-04

3.  Variations in the susceptibility to Coxsackievirus B3-induced myocarditis among different strains of mice.

Authors:  L J Wolfgram; K W Beisel; A Herskowitz; N R Rose
Journal:  J Immunol       Date:  1986-03-01       Impact factor: 5.422

4.  Cardiac myosin-induced myocarditis. Heart autoantibodies are not involved in the induction of the disease.

Authors:  N Neu; B Ploier; C Ofner
Journal:  J Immunol       Date:  1990-12-15       Impact factor: 5.422

5.  The use of sarkosyl in generating soluble protein after bacterial expression.

Authors:  S Frankel; R Sohn; L Leinwand
Journal:  Proc Natl Acad Sci U S A       Date:  1991-02-15       Impact factor: 11.205

6.  Identification of a region in segment 1 of gelsolin critical for actin binding.

Authors:  M Way; B Pope; J Gooch; M Hawkins; A G Weeds
Journal:  EMBO J       Date:  1990-12       Impact factor: 11.598

7.  Diagnostic relevance of humoral and cell-mediated immune reactions in patients with acute viral myocarditis.

Authors:  B Maisch; R Trostel-Soeder; E Stechemesser; P A Berg; K Kochsiek
Journal:  Clin Exp Immunol       Date:  1982-06       Impact factor: 4.330

8.  Anti-idiotypic antibodies, acetylcholine receptor antibodies and disturbed neuromuscular function in healthy relatives to patients with myasthenia gravis.

Authors:  A K Lefvert; R Pirskanen; E Svanborg
Journal:  J Neuroimmunol       Date:  1985-07       Impact factor: 3.478

9.  Cytotoxic and viral neutralizing antibodies crossreact with streptococcal M protein, enteroviruses, and human cardiac myosin.

Authors:  M W Cunningham; S M Antone; J M Gulizia; B M McManus; V A Fischetti; C J Gauntt
Journal:  Proc Natl Acad Sci U S A       Date:  1992-02-15       Impact factor: 11.205

10.  Connective tissue biomatrix: its isolation and utilization for long-term cultures of normal rat hepatocytes.

Authors:  M Rojkind; Z Gatmaitan; S Mackensen; M A Giambrone; P Ponce; L M Reid
Journal:  J Cell Biol       Date:  1980-10       Impact factor: 10.539

View more
  33 in total

Review 1.  Cardiac myosin and the TH1/TH2 paradigm in autoimmune myocarditis.

Authors:  M W Cunningham
Journal:  Am J Pathol       Date:  2001-07       Impact factor: 4.307

2.  Autoimmune sensitization to cardiac myosin leads to acute rejection of cardiac allografts in miniature swine.

Authors:  Gregory R Veillette; Hisashi Sahara; Andrew J Meltzer; Mathew J Weiss; Yoshiko Iwamoto; Karen M Kim; Bruce R Rosengard; James S Allan; Stuart L Houser; David H Sachs; Gilles Benichou; Joren C Madsen
Journal:  Transplantation       Date:  2011-06-15       Impact factor: 4.939

3.  Induction of cardiomyocyte apoptosis by anti-cardiac myosin heavy chain antibodies in patients with acute myocardial infarction.

Authors:  Kun Liu; Liang Shao; Li Wang; Yanping Ding; Guanhua Su; Jue Wang; Yuhua Liao; Zhaohui Wang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2010-11-10

4.  Experimental autoimmune myocarditis in A/J mice is an interleukin-4-dependent disease with a Th2 phenotype.

Authors:  M Afanasyeva; Y Wang; Z Kaya; S Park; M J Zilliox; B H Schofield; S L Hill; N R Rose
Journal:  Am J Pathol       Date:  2001-07       Impact factor: 4.307

Review 5.  Relationship of extraintestinal involvements in inflammatory bowel disease: new insights into autoimmune pathogenesis.

Authors:  K M Das
Journal:  Dig Dis Sci       Date:  1999-01       Impact factor: 3.199

6.  T-Cell-dependent antibody response to the dominant epitope of streptococcal polysaccharide, N-acetyl-glucosamine, is cross-reactive with cardiac myosin.

Authors:  S Malkiel; L Liao; M W Cunningham; B Diamond
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

7.  Immunological relationship between the class I epitope of streptococcal M protein and myosin.

Authors:  A Quinn; K Ward; V A Fischetti; M Hemric; M W Cunningham
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

Review 8.  Unresolved issues in theories of autoimmune disease using myocarditis as a framework.

Authors:  Robert Root-Bernstein; DeLisa Fairweather
Journal:  J Theor Biol       Date:  2014-12-04       Impact factor: 2.691

Review 9.  Molecular Mimicry, Autoimmunity, and Infection: The Cross-Reactive Antigens of Group A Streptococci and their Sequelae.

Authors:  Madeleine W Cunningham
Journal:  Microbiol Spectr       Date:  2019-07

Review 10.  Cardiac troponins and autoimmunity: their role in the pathogenesis of myocarditis and of heart failure.

Authors:  Ziya Kaya; Hugo A Katus; Noel R Rose
Journal:  Clin Immunol       Date:  2009-05-14       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.